Event

Alberto Papi

MD
Univ Di Ferrara;Univ Di Ferrara Centro Asma;University of Ferrara

Massimo Corradi

MD
University of Parma;University of Parma, Italy

Isabella Montagna

MSc
Chiesi Farmaceutici

Mario Scuri

MD, PhD
Chiesi Farmaceutici

Alessandro Guasconi

MSc
Chiesi Farmaceutici

Géraldine Cohuet

MSc
Chiesi Farmaceutici;Chiesi Farmaceutici SpA;Laboratoires CHIESI SAS

Leonardo M. Fabbri

MD
Univ of Ferrara;University of Ferrara

Stefano Petruzzelli

MD, PhD
Chiesi Farmaceutici;Chiesi Farmaceutici S.p.a.

Stefano Vezzoli

MSc
Chiesi Farmaceutici

Dave Singh

MD, NP
Manchester Academic Health Science Centre, The University of Manchester;Medicines Evaluation Unit (MEU), University of South Manchester NHS Foundation Trust;The University of Manchester, University Ho

Jorgen Vestbo

MD, PhD
Manchester Academic Health Sciences Centre, The University of Manchester and Manchester University N;Manchester Academic Health Sciences Centre, The University of Manchester and University Hospital So

Extrafine Formulation of Beclometasone Dipropionate, Formoterol Fumarate, Glycopyrronium (BDP/FF/G) and Exacerbation Recurrence: Post-Hoc Analysis of the TRINITY Study